Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
The Prostate|August 19, 2015
Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic markerAsha Leisser, Konstatin Pruscha, Philipp Ubl, et al.
BMC Cancer|September 8, 2010
Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinomaUrsula M Vogl, Marija Bojic, Wolfgang Lamm, et al.
Urologic Oncology|May 13, 2014
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerStephan Tschirdewahn, Henning Reis, Christian Niedworok, et al.
Urologic Oncology|April 10, 2018
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancerTibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2025
Enhanced vascular inflammation in patients with advanced prostate cancer receiving hormone therapyHolger Einspieler, Dina Muin, Ilva Kristiana Langrate, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomyMehmet Özsoy, Marco Moschini, Harun Fajkovic, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 16, 2003
Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissueGeorg E Steiner, Ursula Stix, Alessandra Handisurya, et al.
The Journal of Urology|October 11, 2015
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell CancerFrank Vom Dorp, Stephan Tschirdewahn, Christian Niedworok, et al.
Clinical Epigenetics|February 26, 2025
Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT studyKilian Kluge, Vincent Lotz, Holger Einspieler, et al.
Urologia Internationalis|May 8, 2014
Management of bone metastases in patients with castration-resistant prostate cancerRichard Cathomas, Zoltan Bajory, Mounira Bouzid, et al.
Pageof 12